Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Opinion in Infectious Diseases

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QCO.0b013e3283486d04PMID 21666458PMCID PMC4059200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapamycin Blocks Production of KSHV/HHV8: Insights into the Anti-Tumor Activity of an Immunosuppressant Drug

  2011cited by this paper
• The increasing burden of HIV-associated malignancies in resource-limited regions.

  2011cited by this paper
• The HIV Protease Inhibitor Nelfinavir Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication In Vitro

  2011cited by this paper
• Intracavitary cidofovir for human herpes virus-8-associated primary effusion lymphoma in an HIV-negative patient.

  2010cited by this paper
• Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.

  2010cited by this paper
• Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.

  2010cited by this paper
• Kaposi's sarcoma and its associated herpesvirus

  2010cited by this paper
• KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

  2010cited by this paper
• International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.

  2010cited by this paper
• Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.

  2010cited by this paper
• Impact of HIV Infection and Kaposi Sarcoma on Human Herpesvirus-8 Mucosal Replication and Dissemination in Uganda

  2009cited by this paper
• AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies.

  2009cited by this paper
• Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood.

  2009cited by this paper
• The Impact of Nelfinavir Exposure on Cancer Development Among a Large Cohort of HIV-Infected Patients

  2009cited by this paper
• Anti-HIV drugs for cancer therapeutics: back to the future?

  2009cited by this paper
• Epstein‐Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

  2009cited by this paper
• Estimation of HIV incidence in San Francisco

  2009cited by this paper
• Nelfinavir: A magic bullet to annihilate cancer cells

  2009cited by this paper
• Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells

  2008cited by this paper
• Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

  2008cited by this paper
• Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era

  2008cited by this paper
• Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.

  2007cited by this paper
• Interactions between HIV-1 Tat and KSHV.

  2007cited by this paper
• Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy

  2006cited by this paper
• Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases.

  2006cited by this paper
• Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.

  2006cited by this paper
• Successful secondary prophylaxis for primary effusion lymphoma with human herpesvirus 8 therapy.

  2006cited by this paper
• Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma

  2005cited by this paper
• The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production.

  2005cited by this paper
• Potent Antiviral Activity of North-Methanocarbathymidine against Kaposi's Sarcoma-Associated Herpesvirus

  2005cited by this paper
• Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

  2005cited by this paper
• Persistence of Kaposi sarcoma-associated herpesvirus (KSHV)-infected cells in KSHV/HIV-1-coinfected subjects without KSHV-associated diseases.

  2005cited by this paper
• Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.

  2004cited by this paper
• Antitumour effects of antiretroviral therapy

  2004cited by this paper
• Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

  2004cited by this paper
• Failure of cidofovir in HIV-associated multicentric Castleman disease.

  2004cited by this paper
• Dissection of the Kaposi's Sarcoma-Associated Herpesvirus Gene Expression Program by Using the Viral DNA Replication Inhibitor Cidofovir

  2004cited by this paper
• Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

  2004cited by this paper
• Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen.

  2003cited by this paper
• Productive Lytic Replication of a Recombinant Kaposi's Sarcoma-Associated Herpesvirus in Efficient Primary Infection of Primary Human Endothelial Cells

  2003cited by this paper
• A pilot study of cidofovir in patients with kaposi sarcoma.

  2003cited by this paper
• Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma

  2003cited by this paper
• Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.

  2003cited by this paper
• Cancer in Africa: epidemiology and prevention.

  2003cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells

  2003cited by this paper
• Effect of Protease Inhibitor-Based Highly Active Antiretroviral Therapy on Survival in HIV-Associated Advanced Kaposi's Sarcoma Patients Treated with Chemotherapy

  2003cited by this paper
• Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus

  2003cited by this paper
• A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma

  2003cited by this paper
• Detection of DNA of Lymphotropic Herpesviruses in Plasma of Human Immunodeficiency Virus-Infected Patients: Frequency and Clinical Significance

  2002cited by this paper
• Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet1

  2002cited by this paper
• Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase.

  2002cited by this paper
• Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998.

  2002cited by this paper
• Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma

  2002cited by this paper
• HHV-8 DNA in blood and the development of HIV-associated Kaposi's sarcoma in the era of HAART--a prospective evaluation.

  2002cited by this paper
• Prospective Study of the Effects of Antiretroviral Therapy on Kaposi Sarcoma‐Associated Herpesvirus Infection in Patients With and Without Kaposi Sarcoma

  2002cited by this paper
• Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.

  2001cited by this paper
• Efavirenz as a substitute for protease inhibitors in HIV-1-infected patients with undetectable plasma viral load on HAART: a median follow-up of 64 weeks.

  2001cited by this paper
• Serological testing for human herpesvirus 8.

  2001cited by this paper
• Spindle Cell Conversion by Kaposi's Sarcoma-Associated Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and Latent Gene Expression in Infected Primary Dermal Microvascular Endothelial Cell Cultures

  2001cited by this paper
• Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.

  2001cited by this paper
• Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS.

  2001cited by this paper
• Identifying human herpesvirus 8 infection: performance characteristics of serologic assays.

  2000cited by this paper
• Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

  2000cited by this paper
• Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells.

  2000cited by this paper
• Identifying Human Herpesvirus 8 Infection: Performance Characteristics of Serologic Assays

  2000cited by this paper
• Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage

  2000cited by this paper
• Human Herpesvirus 8 Open Reading Frame 21 Is a Thymidine and Thymidylate Kinase of Narrow Substrate Specificity That Efficiently Phosphorylates Zidovudine but Not Ganciclovir

  2000cited by this paper
• High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

  2000cited by this paper
• Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.

  2000cited by this paper
• Novel association of haemophagocytic syndrome with Kaposi's sarcoma‐associated herpesvirus‐related primary effusion lymphoma

  2000cited by this paper
• Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS.

  1999cited by this paper
• Cidofovir for the treatment of Kaposi’s sarcoma in an HIV‐negative homosexual man

  1999cited by this paper
• Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

  1999cited by this paper
• Suppression of HHV-8 viremia by foscarnet in an HIV-infected patient with Kaposi's sarcoma and HHV-8 associated hemophagocytic syndrome.

  1998cited by this paper
• Antiviral drug susceptibility of human herpesvirus 8

  1997cited by this paper
• In vitro antiviral drug sensitivity of the Kaposi's sarcoma‐associated herpesvirus

  1997cited by this paper
• Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.

  1997cited by this paper
• Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells

  1997cited by this paper
• Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.

  1997cited by this paper
• Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells.

  1997cited by this paper
• Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines.

  1996cited by this paper
• Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.

  1996cited by this paper
• KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma.

  1996cited by this paper
• Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users relative to homosexual men.

  1996cited by this paper
• Anti‐herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection

  1996cited by this paper
• Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.

  1996cited by this paper
• Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.

  1996cited by this paper
• AIDS-associated Kaposi's sarcoma

  1995cited by this paper
• Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.

  1995cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper
• Long-term remission of Kaposi's sarcoma following foscarnet treatment in HIV-infected patients.

  1994cited by this paper
• AIDS-associated Kaposi's sarcoma.

  1990cited by this paper
• Activation of NF- (cid:2) B by the Latent vFLIP Gene of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for the Spindle Shape of Virus-Infected Endothelial Cells and Contributes to Their Proinflammatory Phenotype

  year unknowncited by this paper

• Immunotherapy of Oncovirus-Induced Cancers: A Review on the Development and Efficacy of Targeted Vaccines

  2025influential citation
• HIV-Associated Multicentric Castleman Disease with Kaposi Sarcoma: A Case Report with 120-Week Follow-Up of HHV-8 After Remission.

  2025cites this paper
• Decoding the molecular complexity of viruses in human cancer: insights into host cell infection, oncogenesis, and therapeutic prospects

  2025cites this paper
• Bladder Adenocarcinoma in a Constellation of Multiple Site Malignancies: An Unusual Case and Systematic Review

  2024cites this paper
• Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly

  2024cites this paper
• An Overview of the Unfolded Protein Response (UPR) and Autophagy Pathways in Human Viral Oncogenesis.

  2024cites this paper
• Nelfinavir Inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly

  2023cites this paper
• Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas

  2023cites this paper
• Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition

  2023cites this paper
• Immune Reconstitution Inflammatory Syndrome Associated Kaposi Sarcoma

  2022cites this paper
• A case report-application of pericardial effusion cytology and next-generation sequencing technology: quick and secure diagnosis of primary effusion lymphoma

  2022cites this paper
• Multimodality imaging findings of infection-induced tumors

  2022cites this paper
• Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients

  2022cites this paper
• The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches.

  2021cites this paper
• Chapter XX Antiviral Treatment and Cancer Control.

  2021cites this paper
• Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial

  2021cites this paper
• Transplant Infectious Disease Evaluation of Cytopenias

  2021cites this paper
• Tissue Pathogens and Cancers: A Review of Commonly Seen Manifestations in Histo- and Cytopathology

  2021cites this paper
• Disseminated AIDS-Related Kaposi Sarcoma Immune Reconstitution Inflammatory Syndrome With Infiltrative Liver Disease

  2021cites this paper
• Kaposi sarcoma: a fresh look.

  2021cites this paper
• Non-Invasive Diagnosis of Pulmonary Kaposi Sarcoma: A Case Report

  2020cites this paper
• Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus

  2019cites this paper
• Kaposi Sarcoma in Solid Organ Transplant Recipients: A challenging Case

  2019influential citation
• Identification of new antiviral agents against Kaposi’s sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation

  2019cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM

  2019cites this paper
• Prevalence of human herpesvirus 8 infection in patients undergoing hemodialysis using nested-PCR

  2019cites this paper
• Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas

  2019cites this paper
• Human herpesvirus 6, 7, and 8 in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Viral-Mediated AURKB Cleavage Promotes Cell Segregation and Tumorigenesis.

  2019cites this paper
• Malignant hepatic vascular tumors in adults: Characteristics, diagnostic difficulties and current management

  2019cites this paper
• Expression of PD-1 and PD-Ls in Kaposi's sarcoma and regulation by oncogenic herpesvirus lytic reactivation.

  2019cites this paper
• USP7-Dependent Regulation of TRAF Activation and Signaling by a Viral Interferon Regulatory Factor Homologue

  2019cites this paper
• MBL2 gene polymorphisms in HHV-8 infection in people living with HIV/AIDS

  2018cites this paper
• CD20-Negative Aggressive Lymphomas

  2018cites this paper
• KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite

  2018cites this paper
• The viruses in the human oncogénesis

  2018cites this paper
• 209 – Human Herpesvirus 8 (Kaposi Sarcoma–Associated Herpesvirus)

  2018cites this paper
• Discovery of acylphloroglucinol-based meroterpenoid enantiomers as KSHV inhibitors from Hypericum japonicum

  2018cites this paper
• The unholy trinity of human herpesvirus 8-associated malignancy in a person living with HIV-1.

  2018cites this paper
• Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review

  2018cites this paper
• Lymphoproliferative Disorders of the Lung

  2017cites this paper
• Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways.

  2017cites this paper
• HHV8 and Kaposi's sarcoma: should we really give up protease inhibitors in all HIV-infected patients?

  2017cites this paper
• Viral Oncology: Molecular Biology and Pathogenesis

  2017influential citation
• Evènements moléculaires spécifiques au cours des adénocarcinomes pulmonaires lépidiques humains et animaux

  2017cites this paper
• Kaposi's sarcoma in HIV-infected patients in the era of new antiretrovirals.

  2017cites this paper
• Human herpesvirus-8 and human cytomegalovirus infections in Bowen's disease: Is there any association?

  2017cites this paper
• Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma

  2017cites this paper
• Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers

  2017cites this paper
• Hepatic Kaposi sarcoma: A case report and review of the literature

  2017cites this paper
• The aetiology of B‐cell lymphoid malignancies with a focus on chronic inflammation and infections

  2017cites this paper
• Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease.

  2016cites this paper
• Shutoff of Host Gene Expression in Influenza A Virus and Herpesviruses: Similar Mechanisms and Common Themes

  2016cites this paper
• Simultaneous Quantification of the 8 Human Herpesviruses in Allogeneic Hematopoietic Stem Cell Transplantation

  2016cites this paper
• HIV-Associated Primary Effusion Lymphoma

  2016cites this paper
• Revisión histórica del sarcoma de Kaposi en la era pre-TARAA (terapia antirretroviral altamente activa): evolución con diferentes esquemas de quimioterapia y remisión con el uso de ganciclovir

  2016cites this paper
• Kaposi ’ s sarcoma in HIV-infected patients : a review of the literature

  2016cites this paper
• KSHV-Mediated Angiogenesis in Tumor Progression

  2016cites this paper
• Enfermedad linfoproliferativa postrasplante renal no asociada a virus de Epstein-Barr

  2016cites this paper
• Hepatobiliary Castleman Disease

  2016cites this paper
• Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes

  2016cites this paper
• The activation of KSHV lytic cycle blocks autophagy in PEL cells

  2015cites this paper
• Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses

  2015cites this paper
• Celecoxib Inhibits the Lytic Activation of Kaposi’s Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK

  2015cites this paper
• Use of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.

  2015cites this paper
• Kaposi's Sarcoma–Associated Herpesvirus Pathogenesis

  2015cites this paper
• Short report Open Access

  2015cites this paper
• Hyaline-vascular Multicentric Castleman's Disease in an immunocompetent patient

  2015cites this paper
• An unusual presentation: A case of Multicentric Castleman's disease presenting as bilateral pleural effusions

  2015cites this paper
• Ceramides promote apoptosis for virus-infected lymphoma cells through induction of ceramide synthases and viral lytic gene expression

  2015cites this paper
• Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy

  2015cites this paper
• [Hyaline-vascular Multicentric Castleman's Disease in an immunocompetent patient].

  2015cites this paper
• NEDDylation Is Essential for Kaposi’s Sarcoma-Associated Herpesvirus Latency and Lytic Reactivation and Represents a Novel Anti-KSHV Target

  2015cites this paper
• CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options

  2015cites this paper
• Regulation of Host and Viral RNA Expression during Gammaherpesvirus Infection

  2015cites this paper
• Efficient Infection of a Human B Cell Line with Cell-Free Kaposi’s Sarcoma-Associated Herpesvirus

  2014cites this paper
• Exposure to ionizing radiation during liver transplantation evaluation, waitlist time, and in the postoperative period: A cause for concern

  2014cites this paper
• Current Concepts in Primary Effusion Lymphoma and Other Effusion-Based Lymphomas

  2014influential citation
• Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.

  2014cites this paper
• KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication

  2014cites this paper
• Virus infection and human cancer: an overview.

  2014cites this paper
• Anti-viral treatment and cancer control.

  2014cites this paper
• Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.

  2014cites this paper
• A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population.

  2014cites this paper
• Characterisation of the interactions between the KSHV ORF57 protein and the human TREX complex

  2014influential citation
• Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.

  2014cites this paper
• Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?

  2014cites this paper
• High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy.

  2014cites this paper
• Accelerated suppression of primary Epstein-Barr virus infection in HIV-infected infants initiating lopinavir/ritonavir-based versus nevirapine-based combination antiretroviral therapy.

  2014cites this paper
• Metastatic Merkel cell carcinoma of the oral cavity in a human immunodeficiency virus-positive patient and the detection of Merkel cell polyomavirus.

  2013cites this paper
• The Cellular Peptidyl-Prolyl cis/trans Isomerase Pin1 Regulates Reactivation of Kaposi's Sarcoma-Associated Herpesvirus from Latency

  2013influential citation
• Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention

  2013cites this paper
• Management of herpesvirus infections.

  2013cites this paper
• Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.

  2013cites this paper
• Human Herpesvirus 8 Disease

  2013cites this paper
• Quantitative determinations of anti-Kaposi sarcoma-associated herpesvirus antibody levels in men who have sex with men.

  2013cites this paper
• Pulmonary manifestations of human herpesvirus-8 during HIV infection

  2013cites this paper
• Quantitative Determinations of Anti-Kaposi’s Sarcoma-Associated Herpesvirus (KSHV) Antibody Levels in Men Who Have Sex with Men

  2013cites this paper
• Efficient Infection of a Human B Cell Line with Cell-Free Kaposi's Sarcoma-Associated Herpesvirus

  2013cites this paper
• Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation

  2013cites this paper